Highlights

  • Galan Lithium shares are up 115.62% in six months and 187.50% over one year.
  • Brokers maintain buy ratings with a AUD 0.60 target price.
  • A AUD 40 million placement will fund production expansion and exploration activity.

Galan Lithium Ltd (ASX:GLN) has recorded a sharp rise in its share price over the past six months, supported by renewed interest across lithium-linked equities and recent corporate activity. Analysts maintain buy ratings and pointing to higher target prices amid rising lithium carbonate prices and ongoing project development.

Share Price Performance Accelerates

Galan Lithium shares were trading at AUD 0.34 on 10 February, up 4.55% during the session. The stock has advanced 115.62% over the past six months and is up 187.50% over the past year.

The move has occurred alongside an increase in lithium carbonate prices, which were quoted at CNY 136,000 per tonne, up 0.37% on the day and 77.43% higher year-on-year, as per TradingEconomics data.

Broker Ratings and Target Prices

Broker coverage on Galan Lithium remains supportive. According to Refinitiv data, the consensus rating stands at buy, with a consensus target price of AUD 0.60.

Canaccord Genuity has also issued a speculative buy rating on the stock, assigning a target price of AUD 0.60. The broker view is aligned with Galan’s planned production expansion and upcoming development milestones.

AUD 40 Million Placement Completed

On 29 January, Galan Lithium announced it had received firm commitments to raise AUD 40 million through an institutional placement priced at AUD 0.41 per share, representing a 2% premium to the five-day VWAP.

The placement was supported by existing substantial shareholder Clean Elements, along with global institutional and sophisticated investors. In addition, company directors committed to subscribe for a further AUD 1 million, subject to shareholder approval.

Expansion at Hombre Muerto West

Proceeds from the capital raising, together with existing cash reserves, will be used to support a 30% expansion of Phase 1 production at the Hombre Muerto West (HMW) lithium project in Argentina. Planned output is set to increase from 4 ktpa LCE to 5.2 ktpa LCE.

Funds will also be allocated to exploration activities at Greenbushes South and general working capital. Phase 1 construction activities at HMW are ongoing, with first lithium chloride concentrate production targeted for the first half of 2026, supported by an existing inventory of approximately 9,500 tonnes LCE in evaporation ponds.

Galan Lithium continues to draw market attention following its share price rise, broker support, and recently completed capital raising. With construction progressing at Hombre Muerto West and production expansion plans underway, upcoming milestones through 2026 are expected to remain a focus for investors tracking the lithium sector.

FAQs

Q1: Why has Galan Lithium’s share price risen sharply?
The share price increase has coincided with rising lithium prices, broker buy ratings, and funding secured for project expansion.

Q2: What is the broker outlook for ASX:GLN?
The stock holds a consensus buy rating, with analysts and Canaccord Genuity assigning a AUD 0.60 target price.

Q3: What will the AUD 40 million placement be used for?
Funds will support Phase 1 expansion at Hombre Muerto West, exploration at Greenbushes South, and working capital.